69P A real-world analysis of treatment-free survival for advanced melanoma patients treated with first-line immune checkpoint inhibitors. (December 2022) - Gupta, M.; Stukalin, I.; Goutam, S.; Meyers, D.E.; Heng, D.Y.C.; Cheng, T.; Navani, V.